Cargando…

Microbiome and metabolome in diagnosis, therapy, and other strategic applications /

Microbiome and Metabolome in Diagnosis, Therapy, and Other Strategic Applications is the first book to simultaneously cover the microbiome and the metabolome in relevant clinical conditions. In a pioneering fashion, it addresses not only the classic intestinal environment, but also the oral, gastric...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Faintuch, Joel (Editor ), Faintuch, Salom�ao (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, [2019]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1080938480
003 OCoLC
005 20231120010335.0
006 m o d
007 cr cnu|||unuuu
008 190104s2019 enka ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d EBLCP  |d UKMGB  |d OCLCF  |d OPELS  |d YDX  |d TXM  |d OCLCQ  |d SFB  |d S2H  |d OCLCO  |d UX1  |d OCL  |d DKU  |d OCLCQ  |d OCLCO  |d K6U  |d OCLCQ  |d OCLCO 
015 |a GBB913030  |2 bnb 
016 7 |a 019207306  |2 Uk 
019 |a 1081250922  |a 1096236267 
020 |a 9780128152508  |q (electronic bk.) 
020 |a 0128152508  |q (electronic bk.) 
020 |z 9780128152492 
020 |z 0128152494 
035 |a (OCoLC)1080938480  |z (OCoLC)1081250922  |z (OCoLC)1096236267 
050 4 |a QR46 
060 4 |a 2019 C-808 
060 4 |a QW 100 
072 7 |a SCI  |x 007000  |2 bisacsh 
082 0 4 |a 572/.472  |2 23 
245 0 0 |a Microbiome and metabolome in diagnosis, therapy, and other strategic applications /  |c [edited by] Joel Faintuch, Salomao Faintuch. 
264 1 |a London, United Kingdom :  |b Academic Press,  |c [2019] 
300 |a 1 online resource (xxvii, 472 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 |a Online resource; title from PDF title page (EBSCO, viewed January 10, 2019). 
505 0 |a Germ-Free Animals as a Tool to Study Indigenous Microbiota -- Germ-Free Mouse Technology in Cardiovascular Research -- The Gut Microbiome Beyond the Bacteriome-The Neglected Role of Virome and Mycobiome in Health and Disease -- Techniques for Phenotyping the Gut Microbiota Metabolome -- Metabolomics Tools and Information Retrieval in Microbiome Hacking -- Laboratory Simulators of the Colon Microbiome -- Potential of Metabolomics to Breath Tests -- Metabolome and Microbiome From Infancy to Elderly -- The Oral Microbiome -- The Gastric Microbiome in Benign and Malignant Diseases -- The Human Vaginal Microbiome -- Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine -- Role of the Microbiome in Intestinal Barrier Function and Immune Defense -- The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric Surgery -- Use of Probiotics in Inflammatory Bowel Disease -- Current Status of Fecal Microbiota Transplantation -- Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials -- Current Options for Fecal Transplantation in Clostridium Difficile Infection -- Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy -- The Unknown Effect of Antibiotic-Induced Dysbiosis on the Gut Microbiota -- The Myth and Therapeautic Potentials of Postbiotics -- The Microbiome and Metabolome in Metabolic Syndrome -- The Gut Microbiota as a Therapeutic Approach for Obesity -- The Gut Microbiome After Bariatric Surgery -- Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management -- The Emerging Role of Microbiome-Gut-Brain Axis in Functional Gastrointestinal Disorders -- The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease -- The Microbiome and Metabolome in Alcoholic LIver Disease -- The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis -- Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis? -- The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease -- The Oral, Genital and Gut Microbiome in HIV Infection -- The Gut Microbiome in Autoimmune Diseases -- The Gut Microbiome and Metabolome in Multiple Sclerosis -- Connections Between Gut Microbiota and Bone Health -- The Gut Microbiome in Chronic Kidney Disease -- Dysbiosis in Benign and Malignant Diseases of the Exocrine Pancreas -- Importance of the Microbiome and the Metabolome in Cancer -- The Microbiome in Graft Versus Host Disease -- Impact of the Gut Microbiome on Behavior and Emotions -- The Gut Microbiome in Vegetarians -- Metformin: A Candidate Drug to Control the Epidemic of Diabetes and Obesity by Way of Gut Microbiome Modification -- Deleterious Impact of Smog on the Intestinal Bacteria -- New-Generation Probiotics: Perspectives and Applications -- Fecal Microbiota Transfer and Inflammatory Bowel Disease: A Therapy or Risk? -- Precision Medicine: The Microbiome and Metabolome. 
520 |a Microbiome and Metabolome in Diagnosis, Therapy, and Other Strategic Applications is the first book to simultaneously cover the microbiome and the metabolome in relevant clinical conditions. In a pioneering fashion, it addresses not only the classic intestinal environment, but also the oral, gastric, lung, skin and vaginal microbiome that is in line with the latest investigations. Nonbacterial microbiomes, such as fungi and viruses are not overlooked, and the plasma microbiome is also discussed. As plasma, brain, placenta, tumor cells, and other sterile fluids and tissues, are increasingly recognized to potentially host a microbiome, albeit a limited one, this is a timely resource. The book's editors were fortunate to have the input of renowned collaborators from nearly all continents. This is truly an international effort that brings the latest in the field to students and professionals alike. 
650 0 |a Microorganisms. 
650 0 |a Bacteria. 
650 0 |a Microorganisms  |x Therapeutic use. 
650 0 |a Bacteria  |x Therapeutic use. 
650 0 |a Medical microbiology. 
650 0 |a Probiotics. 
650 2 |a Bacteria  |0 (DNLM)D001419 
650 2 |a Probiotics  |0 (DNLM)D019936 
650 6 |a Micro-organismes.  |0 (CaQQLa)201-0014998 
650 6 |a Bact�eries.  |0 (CaQQLa)201-0004295 
650 6 |a Micro-organismes  |0 (CaQQLa)201-0014998  |x Emploi en th�erapeutique.  |0 (CaQQLa)201-0373975 
650 6 |a Bact�eries  |0 (CaQQLa)201-0004295  |x Emploi en th�erapeutique.  |0 (CaQQLa)201-0373975 
650 6 |a Microbiologie m�edicale.  |0 (CaQQLa)201-0004318 
650 6 |a Probiotiques.  |0 (CaQQLa)201-0274005 
650 7 |a microorganisms.  |2 aat  |0 (CStmoGRI)aat300252166 
650 7 |a SCIENCE  |x Life Sciences  |x Biochemistry.  |2 bisacsh 
650 7 |a Bacteria  |2 fast  |0 (OCoLC)fst00825152 
650 7 |a Medical microbiology  |2 fast  |0 (OCoLC)fst01014362 
650 7 |a Microorganisms  |2 fast  |0 (OCoLC)fst01019928 
650 7 |a Microorganisms  |x Therapeutic use  |2 fast  |0 (OCoLC)fst01019969 
650 7 |a Probiotics  |2 fast  |0 (OCoLC)fst01740530 
700 1 |a Faintuch, Joel,  |e editor. 
700 1 |a Faintuch, Salom�ao,  |e editor. 
776 0 8 |i Print version:  |t Microbiome and metabolome in diagnosis, therapy, and other strategic applications.  |d London, United Kingdom : Academic Press, [2019]  |z 0128152494  |z 9780128152492  |w (OCoLC)1044866471 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128152492  |z Texto completo